Exp Mol Med.
2008 Dec;40(6):669-676. 10.3858/emm.2008.40.6.669.
Increased in vivo immunological potency of HB-110, a novel therapeutic HBV DNA vaccine, by electroporation
- Affiliations
-
- 1Research Laboratories, Dong-A Pharm. Co., Ltd. Yongin, Korea.
- 2National Research Laboratory of DNA Medicine, Division of Molecular and Life Sciences, Pohang University of Science and Technology, Pohang, Korea.
- 3Interdisciplinary Program of Biochemical Engineering, and Biotechnology, Seoul National University, Seoul, Korea. byungkim@snu.ac.kr
- KMID: 1072947
- DOI: http://doi.org/10.3858/emm.2008.40.6.669
Abstract
- Pulse-induced permeabilization of cellular membranes, generally referred to as electroporation (EP), has been used for years as a tool to increase macromolecule uptake in tissues, including nucleic acids, for gene therapeutic applications, and this technique has been shown to result in improved immunogenicity. In this study, we assessed the utility of EP as a tool to improve the efficacy of HB-110, a novel therapeutic DNA vaccine against chronic hepatitis B, now in phase 1 of clinical study in South Korea. The potency of HB-110 in mice was shown to be improved by EP. The rapid onset of antigen expression and higher magnitude of humoral and cellular responses in electric pulse-treated mice revealed that EP may enable a substantial reduction in the dosage of DNA vaccine required to elicit a response similar in magnitude to that achievable via conventional administration. This study also showed that EP-based vaccination at 4-week-intervals elicited a cellular immune response which was about two-fold higher than the response elicited by conventional vaccination at 2-week intervals. These results may provide a rationale to reduce the clinical dose and increase the interval between the doses in the multidose vaccination schedule. Electric pulsing also elicited a more balanced immune response against four antigens expressed by HB-110: S, preS, Core, and Pol.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- DNA vaccines targeting human papillomavirus-associated diseases: progresses in animal and clinical studies
- Marker Gene Transfer into Cells of Rat Achilles Tendon by In Vivo Electroporation
- Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases
- The Characteristics of RNA Vaccine; its Strengths and Weaknesses
- Hepatitis B vaccination and immunotherapies: an update
